Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze VYNE stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate VYNE investment potential.

What is VYNE stock price today?

Get real-time VYNE stock price, historical data, and price charts on Financhill. Track VYNE performance with our advanced analysis tools.

Is VYNE a good investment?

Evaluate VYNE investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy VYNE stock?

To buy VYNE stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of VYNE?

View detailed market capitalization data and company valuation metrics for VYNE on our comprehensive analysis page.

What is the P/E ratio of VYNE?

Use our fundamental analysis tools to view VYNE P/E ratio and compare valuation metrics with industry peers.

What are VYNE earnings?

View VYNE earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

VYNE Therapeutics, Inc. 10K Form

Sell

VYNE
VYNE Therapeutics, Inc.

Last Price:

$0.37

Seasonality Move:

-5.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-04-20	10K	VYNE/VYNE Therapeutics, Inc. Annual
2021-03-04	10K	VYNE/VYNE Therapeutics, Inc. Annual
2020-11-05	10Q	VYNE/VYNE Therapeutics, Inc. Quarterly
2020-08-06	10Q	VYNE/VYNE Therapeutics, Inc. Quarterly
2020-05-11	10Q	VYNE/VYNE Therapeutics, Inc. Quarterly
2020-03-03	10K	VYNE/VYNE Therapeutics, Inc. Annual

Receive VYNE News And Ratings

See the #1 stock for the next 7 days that we like better than VYNE

VYNE Financial Statistics

Sales & Book Value

Annual Sales:	$501K
Cash Flow:	$-7.1M
Price / Cash Flow:	0
Annual Sales:	$1.01
Price / Book:	0.39

Profitability

EPS (TTM):	-0.78870
Net Income (TTM):	$-33.8M
Gross Margin:	$497K
Return on Equity:	-73.23%
Return on Assets:	-60.26%

VYNE Therapeutics, Inc. Earnings Forecast

Key VYNE Therapeutics, Inc. Financial Ratios

The Gross Profit Margin over the past 5 years for VYNE is 99.20%.
The Selling, General & Administrative Expenses for VYNE have been equal to 2,633.13% of Gross Profit Margin.
The Research & Development expenses have been 6,176.85% of Revenue.
The Net Earning history of VYNE is -7,945.51% of Total Revenues.
Per Share Earnings over the last 10 years have been positive in 5 years.

VYNE Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	VYNE
CUSIP:	92941V
Website:	vynetherapeutics.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	8.87
Quick Ratio:	8.09

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

VYNE Technical Analysis vs Fundamental Analysis